Mathew Shane Maurer MD

Cardiology•New York, NY

Heart Failure & Transplantation, Cardiovascular Disease Genetics

Associate Professor, Medicine, Columbia University College of Phys & Surg

Request appointment

173 Fort Washington AvenueFloor 4, Suite 617New York, NY 10032
Book by Phone+1(765) 590-2559

Overview of Dr. Maurer

Dr. Mathew Maurer is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Mount Sinai School of Medicine and has been in practice 25 years. He specializes in cardiac amyloidosis, geriatric cardiology and heart failure & transplantation.

Education & Training

New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 1996 - 1999
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1992 - 1996
Icahn School of Medicine at Mount SinaiClass of 1992

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2020 - Present
NY State Medical License 1994 - 2027
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013-2017
CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2017
CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2017

Clinical Trials

Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)
COMPLETED
PHASE2
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
TERMINATED
PHASE4
Geriatric Out of Hospital Randomized Meal Trial in Heart Failure
COMPLETED
NA

Publications & Presentations

PubMed

Long-Term Outcomes of Mayo Stage IIIb AL Amyloidosis Treated With Daratumumab-Based Frontline Therapy.
Simon Zhen, Sorina Nicoleta Bandelita, Divaya Bhutani, Mathew S Maurer, Karan Wats
American Journal of Hematology. 2026-09-01
Left Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: A Secondary Analysis of the HELIOS-...
Karola S Jering, Alireza Manafi, Brian L Claggett, Nicole K Bart, Narayana Prasad
JAMA Cardiology. 2026-08-19
First clinical experience with the Transthyretin Amyloidosis-Quality of Life questionnaire (ATTR-QoL): associations with clinical characteristics and established patie...
Dimitrios Bampatsias, Sergio Teruya, Alfonsina Mirabal Santos, Juliana C Levy, Kristen Hsu
European Heart Journal. Quality of Care & Clinical Outcomes. 2026-08-11

Journal Articles

Insufficient Calorie Intake Worsens Post-Discharge Quality of Life and Increases Readmission Burden in Heart Failure
Hannah R Rosenblum, Mathew S Maurer, Scott L Hummel, JACC: Heart Failure
Early Diagnosis of Cardiac Amyloidosis by Carpal Tunnel Surgery
Frederick L Ruberg, Mathew S Maurer, ScienceDirect
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Mathew S Maurer, Mazen Hanna, Martha Grogan, Marla B Sultan, Sanjiv J Shah, The New England Journal of Medicine

Lectures

A Heart Biopsy Must not be do?e: The Role of Imaging and Newer Diagnostic Strategies
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Get the Diagnosis Right: Identifying Amyloidosis in Your Patients
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Are You Infiltrated or Just fat? Should we Screen for Infiltrative Disease Prior to Aortic Valve Replacement?.
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

Clinical Outcomes of Older Adults in the US Listed for Heart TransplantationNovember 2021
ACC CardiaCast: Understanding AL and ATTR Cardiac AmyloidosisMarch 2021
More Than Meets the Eye: Time for a New Imaging Paradigm to Test for Cardiac AmyloidosisJanuary 2018

Press Mentions

2025 HFSA CME Symposium - Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient OutcomesAugust 19th, 2025
What Is Cardiac Amyloidosis?August 4th, 2025
Vutrisiran and All-Cause Mortality, Prognostic Implication of sTTR Levels in Patients with ATTR-CM | JACC Special Focus IssueMay 21st, 2025

Grant Support

Mosaic loss of the Y chromosome in transthyretin (ATTR) cardiac amyloidosisBOSTON MEDICAL CENTER2026–2030
Screening for Cardiac Amyloidosis with a Blood Biomarker in Minority Populations – SCABB-MPUT SOUTHWESTERN MEDICAL CENTER2025–2029
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac AmyloidosisCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2028
SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations)COLUMBIA UNIVERSITY HEALTH SCIENCES2019–2025
Midcareer Mentoring Award For Patient Oriented Research In Geriatric CardiologyNational Institute On Aging2010–2011